Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Adenylate Kinase 2 (AK2) (Middle Region) Peptide

AK2 Reactivity: Human Host: Synthetic BP, WB
Catalog No. ABIN5510922

Quick Overview for Adenylate Kinase 2 (AK2) (Middle Region) Peptide (ABIN5510922)

Target

Adenylate Kinase 2 (AK2)

Origin

Human

Source

  • 4
Synthetic

Application

Blocking Peptide (BP), Western Blotting (WB)
  • Protein Region

    Middle Region

    Sequence

    LIHPKSGRSY HEEFNPPKEP MKDDITGEPL IRRSDDNEKA LKIRLQAYHT

    Characteristics

    This is a synthetic peptide designed for use in combination with anti- AK2 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
  • Application Notes

    Optimal working dilution should be determined by the investigator.

    Restrictions

    For Research Use only
  • Format

    Lyophilized

    Reconstitution

    Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.

    Storage

    -20 °C

    Storage Comment

    For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
  • Target

    Adenylate Kinase 2 (AK2)

    Background

    Adenylate kinases are involved in regulating the adenine nucleotide composition within a cell by catalyzing the reversible transfer of phosphate groups among adenine nucleotides. Three isozymes of adenylate kinase, namely 1, 2, and 3, have been identified in vertebrates, this gene encodes isozyme 2. Expression of these isozymes is tissue-specific and developmentally regulated. Isozyme 2 is localized in the mitochondrial intermembrane space and may play a role in apoptosis. Mutations in this gene are the cause of reticular dysgenesis. Alternate splicing results in multiple transcript variants. Pseudogenes of this gene are found on chromosomes 1 and 2.

    Alias Symbols: ADK2

    Protein Size: 224

    Gene ID

    204

    NCBI Accession

    NM_001199199, NP_001186128
You are here:
Chat with us!